Analyzing PacificHealth Laboratories (OTCMKTS:PHLI) & Cresco Labs (OTCMKTS:CRLBF)

Cresco Labs (OTCMKTS:CRLBF) and PacificHealth Laboratories (OTCMKTS:PHLI) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, institutional ownership and valuation.

Insider and Institutional Ownership

0.1% of Cresco Labs shares are owned by institutional investors. 38.0% of PacificHealth Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Cresco Labs and PacificHealth Laboratories’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cresco Labs	-23.07%	-17.03%	-5.13%
PacificHealth Laboratories	N/A	N/A	N/A

Earnings & Valuation

This table compares Cresco Labs and PacificHealth Laboratories”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cresco Labs	$770.89 million	1.06	-$175.52 million	($0.47)	-3.55
PacificHealth Laboratories	N/A	N/A	N/A	N/A	N/A

PacificHealth Laboratories has lower revenue, but higher earnings than Cresco Labs.

Analyst Recommendations

This is a summary of recent ratings and target prices for Cresco Labs and PacificHealth Laboratories, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cresco Labs	0	2	2	2	3.00
PacificHealth Laboratories	0	0	0	0	N/A

Cresco Labs currently has a consensus price target of $2.50, indicating a potential upside of 49.70%.

About Cresco Labs

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.

About PacificHealth Laboratories

PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; ENDUROX EXCEL, an exercise supplement; and 2ND SURGE, an ultra energy gel. It also offers ACCELERADE HYDRO for less intense workouts use before, during, and after workouts for hydration, energy, and recovery. The company markets its products to various distribution channels, including sports specialty and natural product retailers and chains, as well as markets their products through its Website. PacificHealth Laboratories, Inc. was founded in 1995 and is based in Matawan, New Jersey.